investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
Thomas Ried
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Gert Auer
Karolinska Institute
Stockholm, Sweden
Thomas Ried
National Cancer Institute (NIH)
Rockville, United States
Related projects
Arunasree Kalle
Study the Methylation and Acetylation Status of Xi and Xa Chromosome in Normal and Cancerous Breast Epithelial Cells
Breast
Gregory J Hannon
Cold Spring Harbor Laboratory Cancer Research Center
Breast
Ann Marie Pendergast
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
Breast
Lali K Medina-Kauwe
Tumor Targeted Corroles for Detection and Intervention
Breast
Bisrat G Debeb
Elucidate the role of miR-141 in brain metastasis from breast cancer
Breast
Katarzyna Slowinska
Rigid-rod Peptides as Nanocarriers for Delivery of Cancer Drugs
Breast
Aliccia Bollig-Fischer
The Molecular Link from Type 2 Diabetes to Breast Cancer
Breast
Jie Liu
Structure and Function of the Tumor Suppressor Protein BRCA2
Breast
Mala Pande
Susceptibility Markers for a Breast-Colon Cancer Phenotype
Breast